相关实验视频

Updated: Jun 23, 2025

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

[对于结肠直肠癌周转移的腹膜内化疗]

J W Ye¹, H B Hu¹, R Luo¹

¹Department of General Surgery (Colorectal Surgery), the Sixth Affiliated Hospital, Sun Yat-sen University;Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University;Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University,Guangdong Province Biomedical Material Conversion and Evaluation Engineering Technology Center, Guangzhou 510655, China.

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

|June 20, 2024

概括

腹腔内化学疗法为结直肠癌腹腔内转移提供了有前途的治疗选择. 需要进一步的研究来优化其应用并改善患者的治疗结果.

科学领域:

在瘤学瘤学.
手术瘤学手术瘤学
胃肠道瘤学胃肠道瘤学

背景情况:

腹转移是结直肠癌的常见和不良预后指标.
目前的治疗依赖于细胞还原性手术和全身化疗,腹腔内化疗作为关键补充剂.

研究的目的:

审查结直肠癌周转移的腹腔内化学疗法的发展,方法和当前状态.
突出未来研究领域,以标准化和提高治疗疗效.

主要方法:

审查关于腹腔内化疗方式的现有文献.
对治疗方法的分析,包括HIPEC,NIPS,EPIC,SPIC,NIPEC和PIPAC.
讨论优化代理选择,时间和协议的研究需求.

主要成果:

内化疗包括各种方法,如HIPEC和PIPAC.
标准化需要进一步调查机制,代理和管理协议.
序列性腹腔内化疗的可行性需要探索.

结论:

腹腔内化学疗法为结直肠癌的腹腔内转移提供了一个重要的治疗途径.
持续的研究对于完善技术和改善临床应用至关重要.
优化腹腔内化学疗法将加强对这种具有挑战性的疾病的管理.

更多相关视频

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Published on: March 3, 2023

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

相关概念视频